Table 5 Comparisons of IESF for studies
Study | Study characteristics | Total Pts (n) | Age | “Nodule” rate | Clinically relevant IESF | Total IF rate |
|---|---|---|---|---|---|---|
Our study | EOS imaging IESF rate | 503 44.5% male | Mean 60 yo Range: 18–91 yo | Nodules, only: 0.99% Nodules + granulomas 2.2% | Major and Moderate: 4.8% Clinically relevant: 0.8% | 60.4% |
Den Harder et al. [31] | Cardiac patients undergoing preop CXR IF rate Included spinal abnormalities | 1136 70% male | Mean: 65 yo No Range reported | Pulm mass: 0.8% | Findings that resulted in further workup: 1.3% | 50% (patients that had 1 + abnormalities on CXR) |
Van Vugt et al. [32] | European study, multicenter CXR for acute cough in outpatient clinic IF rate | 2823 43.5% male | Mean: 53 yo Range: 18–92 yo | Nodule, density shadow rate: 1.8% | Clinically relevant: 3% | Mean: 19% Range (from individual centers): 0–25% |
Quattrochi et al. [12] | Lumbar MRI (1.5 T) IESF rate No thoracic findings in study | 3000 48.4% male | Mean: 59.3 yo Range: 16–91 yo | – | E3 + E4: 11.3% 16.5% of patients E4: 2.5% E2: 57.4% | 68.6% |
Semaan et al. [13] | Lumbar MRI IESF rate | 3024 45% male | Mean: 63 yo Range: 18–95 yo | – | E3 + E4: 6.65% E2: 20% E4: 1.25% | 22% |
Lee et al. [24] | CT lumbar spine for LBP IESF rate | 400 53% male | Mean: 49 yo Range: 20–91 yo | – | E3 + E4: 14.8% E4: 4.3% E2: 25.3% | 40.5% |